최근 메치실린 황색포도상구균(MRSA)를 살균하기 위해 매우 진보된 "오존 살균 시스템"을 도입했다는 영국 병원의 소식을 전하는 최신 뉴스입니다.
연락처도 자세히 나와 있군요!
오존이 무용지물이라면 유럽에서는 왜 이토록 관용적이고 포용적일까요?
전에 말씀드린 것처럼 무려 5000만명의 목숨을 앗아간 집단 질병의 역사적 기록이 생생히 남아있기 때문입니다.
여러분!
정신 좀 차려 주위를 돌아보세요!
당신과 당신의 가족의 생명을 보호할 그 무엇을 원한다면, 오존도 쓸모가 있는 매우 유용한 살균소독제입니다.
절대로 낮은 농도에서는 사람이 상하지 않습니다.
지난 만 4년간 가족들과 자연계 오존 농도(0.05ppm 정도)에서 생활해 온 제 경험으로 비추어 볼때 오히려 건강이 좋아졌습니다.
코에 제품을 가까이 하지 마시고, 높은 장소에 거리를 두고 사용하시되 기본적으로 자연환기 상태에서 생활하면 전혀 이상이 없습니다.
이 사이트에서처럼 오존을 독가스라고 서슴없이 표현하는 것은, 코끼리 꼬리를 잡고, 생쥐라고 말하는 것과 똑같습니다.
과학을 믿으세요?
아니면 막연한 심증을 믿으십니까?
만약 전자라면 우리 모두는 괜찮습니다.
Now all is well!
-------------------------------------------------------------------
MRSA - Advanced Ozone Technology To Be Trialled In Hospitals
Main Category: MRSA / Drug Resistance News
Article Date: 03 Jan 2007
Stockport-based environmental hygiene specialist Steritrox has been awarded a research grant to develop their advanced ozone system to combat the growing threat to public health of MRSA, Clostridium Difficile and other acquired infections in hospitals.
The £168,000 research and development grant was awarded to Steritrox by the Northwest Regional Development Agency on behalf of the Department of Trade & Industry.
The Steritrox system was originally developed for sanitizing high care production facilities in the food industry and is currently being used by some of Europe’s largest food manufactures to control potentially harmful bacteria and contaminants.
The research grant will be used to develop a new portable Steritrox system to be used in hospital wards, operating theatres and general areas when a threat of potential infection is identified.
Peter Townley, managing director at Steritrox said: "The technology behind our hygiene system has proven extremely effective at killing bacteria, moulds and spoilage agents in the food industry. This grant from the DTI will allow us to develop a similar system for the medical sector with the aim of providing appropriate levels of protection for hospitals and medical facilities on a truly global scale."
The technology behind the system is based on the company’s advanced oxidation techniques that uses only naturally occurring elements to deliver a massive biocidal charge over a very short period of time - usually much less than an hour.
After a short exposure time a unique quenching system quickly absorbs any remaining vapours enabling the whole process to be completed in under an hour leaving the room sanitized and completely free of any harmful chemical residuals.
"It is expected that the development project and field trial programme will be complete in 12 months time. We hope we will then have developed an effective weapon to be deployed in the fight against the growing threat of hospital super bugs, as well as providing a credible defence process against similar attacks in the future."
Steritrox(TM) Ltd
Cromwell Road
Bredbury
Stockport
Cheshire, SK6 2RH
UK
Tel: 0161 430 8721
Fax: 0161 612 6229
info@steritrox.co.uk
http://www.steritrox.co.uk
연락처도 자세히 나와 있군요!
오존이 무용지물이라면 유럽에서는 왜 이토록 관용적이고 포용적일까요?
전에 말씀드린 것처럼 무려 5000만명의 목숨을 앗아간 집단 질병의 역사적 기록이 생생히 남아있기 때문입니다.
여러분!
정신 좀 차려 주위를 돌아보세요!
당신과 당신의 가족의 생명을 보호할 그 무엇을 원한다면, 오존도 쓸모가 있는 매우 유용한 살균소독제입니다.
절대로 낮은 농도에서는 사람이 상하지 않습니다.
지난 만 4년간 가족들과 자연계 오존 농도(0.05ppm 정도)에서 생활해 온 제 경험으로 비추어 볼때 오히려 건강이 좋아졌습니다.
코에 제품을 가까이 하지 마시고, 높은 장소에 거리를 두고 사용하시되 기본적으로 자연환기 상태에서 생활하면 전혀 이상이 없습니다.
이 사이트에서처럼 오존을 독가스라고 서슴없이 표현하는 것은, 코끼리 꼬리를 잡고, 생쥐라고 말하는 것과 똑같습니다.
과학을 믿으세요?
아니면 막연한 심증을 믿으십니까?
만약 전자라면 우리 모두는 괜찮습니다.
Now all is well!
-------------------------------------------------------------------
MRSA - Advanced Ozone Technology To Be Trialled In Hospitals
Main Category: MRSA / Drug Resistance News
Article Date: 03 Jan 2007
Stockport-based environmental hygiene specialist Steritrox has been awarded a research grant to develop their advanced ozone system to combat the growing threat to public health of MRSA, Clostridium Difficile and other acquired infections in hospitals.
The £168,000 research and development grant was awarded to Steritrox by the Northwest Regional Development Agency on behalf of the Department of Trade & Industry.
The Steritrox system was originally developed for sanitizing high care production facilities in the food industry and is currently being used by some of Europe’s largest food manufactures to control potentially harmful bacteria and contaminants.
The research grant will be used to develop a new portable Steritrox system to be used in hospital wards, operating theatres and general areas when a threat of potential infection is identified.
Peter Townley, managing director at Steritrox said: "The technology behind our hygiene system has proven extremely effective at killing bacteria, moulds and spoilage agents in the food industry. This grant from the DTI will allow us to develop a similar system for the medical sector with the aim of providing appropriate levels of protection for hospitals and medical facilities on a truly global scale."
The technology behind the system is based on the company’s advanced oxidation techniques that uses only naturally occurring elements to deliver a massive biocidal charge over a very short period of time - usually much less than an hour.
After a short exposure time a unique quenching system quickly absorbs any remaining vapours enabling the whole process to be completed in under an hour leaving the room sanitized and completely free of any harmful chemical residuals.
"It is expected that the development project and field trial programme will be complete in 12 months time. We hope we will then have developed an effective weapon to be deployed in the fight against the growing threat of hospital super bugs, as well as providing a credible defence process against similar attacks in the future."
Steritrox(TM) Ltd
Cromwell Road
Bredbury
Stockport
Cheshire, SK6 2RH
UK
Tel: 0161 430 8721
Fax: 0161 612 6229
info@steritrox.co.uk
http://www.steritrox.co.uk
